We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

Lower GI
Poster (digital)
Clinical
Rectal cancer with LPLN - T and node characteristics analysis: impact of SIB on oncological outcomes
Elisa Meldolesi, Italy
PO-1311
CoDMI algorithm and survival analysis: first clinical application in rectal cancer
Francesca De Felice, Italy
PO-1312
Laparoscopic uterus transposition to preserve fertility in young patients with pelvic radiation
Simone Marnitz, Germany
PO-1313
CLINICAL OUTCOMES IN ANAL CANCER. IMPACT OF RADIATION TECHNIC
Mireia Valero, Spain
PO-1314
CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer
Martina Mori, Italy
PO-1315
Low regrowth after cCR in non-operative TNT management of locally advanced rectal cancer patients
Ugur Selek, Turkey
PO-1316
Chemoradiotherapy-treated anal cancer patients radiomics-based stratification to predict DSS.
Viola De Luca, Italy
PO-1317
MRI based radiomics as imaging biomarker for response to Neoadjuvant Chemoradiation in Rectal Cancer
ABHINAV PUPPALWAR, India
PO-1318
Neoadjuvant RT dose escalation for LARC in the new era of radiotherapy; a review of literature
Durim Delishaj, Italy
PO-1319
Pelvic chemoradiation after chemotherapy in patients with advanced anal squamous cell carcinoma
Jihane Boustani, France
PO-1320
Prognostic factors for anal cancer treated with conformal radiotherapy – a systematic review
Stelios Theophanous, United Kingdom
PO-1321
NAR Score validation in TNT (Total Neoadjuvant treatment) for locally advanced rectal cancer
ILAN DANIEL PERROT ROSENBERG, Chile
PO-1322
Narrowing the difference in dose delivery for IOERT and IOBT for rectal cancer
An-Sofie Verrijssen, The Netherlands
PO-1323
Accelerated hypofractionation with SIB-IMRT in Anal Cancer : assessment of efficacy and toxicity
Sara Lucidi, Italy
PO-1324
Automated rectal tumor segmentation with inter-observer variability-based uncertainty estimates
Luca Weishaupt, USA
PO-1325
PET/CT parameters to predict survival and recurrence in patients with locally advanced anal cancer
Mathias PERAZZI, France
PO-1326
Fractal-based radiomic approach to tailor the chemotherapy treatment in rectal cancer
Giuditta Chiloiro, Italy
PO-1327
Prospective assesment of quality of life before, during and after CRT in patients with anal cancer
Frederik Fuchs, Germany
PO-1328
Predictive factors for pathologic good response after the neoadjuvant CRT of rectal cancer
Yi-En Lin, Taiwan
PO-1329